4 February 2025
F
UEL
R
E
NGINES
F
RIEND
O
F
T
HE
E
CONOMY
Low base to push combined capex growth to 13.4% in FY26BE
Budgeted at 3.7% of GDP in FY26, lower than in pre-Covid years
What is the budgeted capex growth and what should be included in the capex budget? The answers to these questions
should not be a matter of confusion but they are. Therefore, we attempt these questions in this note.
As of last year, the Center’s budgeted capex estimates were widely quoted, which were growing at a fast pace. In the
past many years, we have highlighted that off-budget capex (done by central public sector enterprises or CPSEs) must be
included in the budgeted capex to find out the true capex estimates. While the inclusion of CPSEs is a widely accepted
practice now, another line item – called ‘grants for creation of capital assets’ to states/UTs – is included in the budgeted
and CPSEs capex this year to estimate growth in the Center’s capex.
Based on the headline data, growth in the Center’s capital spending is revised to 7.3% YoY in FY25RE (from 16.9% YoY in
FY25BE) and is budgeted to grow 10.1% YoY in FY26BE. CPSEs’ capex is budgeted to grow 12.9% YoY in FY26BE, from a
decline of 1.9% YoY in FY25RE (13.0% YoY in FY25BE), and the ‘grants for creation of capital assets’ are budgeted to grow
at a 14-year high pace of 42.4% YoY in FY26BE, compared with a fall of 1.3% YoY in FY25RE (21.7% YoY in FY25BE). All
combined, the aggregate capex is budgeted at INR19.8t in FY26BE from INR17.0t in FY25RE (INR18.7tn in FY25BE),
implying a growth of 16.4% YoY next year, from a revised growth of 3.5% this year (from 17.1% YoY in FY25BE).
There are good reasons why ‘grants for creation of capital assets’ should not be included in the Center’s capex. Many of
these schemes, such as MGNREGA or PM Surya Ghar Muft Bijli Yojana, are not capex, and more importantly, such
expenditure on capital assets will be included in states’ capex.
Three further adjustments are needed to understand the true extent of the GoI’s true capex: 1) The Center’s capital
spending has two parts – capital outlays/expenditure (or capex) and loans and advances (L&As). The latter must be
excluded, as they would be included in states’ capex; 2) The GoI has included the equity infusion of INR339b into BSNL in
FY26BE under capex, which must also be excluded, as it does not have any capex multiplier; and 3) Investments of Food
Corporation of India (FCI), within CPSEs capex, must be excluded since they are operational expenses.
After adjusting these factors, the combined capex is budgeted to grow 13.4% YoY in FY26BE vs. 4.7% growth in FY25RE
(revised from 14.3% YoY in FY25BE). Further, the GoI has included INR417b as ‘New Schemes’ under the Ministry of
Finance, for which we could not find any details (vs. INR91b in FY25RE, revised from INR626b in FY25BE). The combined
capex growth will ease to 10.7% YoY in FY26BE, from 3.9% YoY in FY25RE (8.5% YoY in FY25BE), if we exclude the
allocation to ‘New Schemes’.
Overall, the combined capex is budgeted at 3.7% of GDP in FY26BE, better than 3.6% in FY25RE but lower than 3.8% of
GDP in FY24 and 3.9% of GDP in the pre-Covid years.
Exhibit 1: Center’s capex budgeted to grow 10-14% YoY in
FY26…
Center's capital spending (% YoY)
48
39.0
36
24.8
24
25.0
12
0
FY22
FY23
FY24
22.2
24.0
7.3
4.9
3.7
9.7
FY26BE
13.6
10.1
28.3
Headline
Capex^
Adj capex*
24
18
12
6
6.9
0
FY22
@Center + CPSEs
FY23
FY24
Exhibit 2: …and the combined capex, with CPSEs#, is
targeted to grow 11-13%
Combined@ capital spending# (% YoY)
Headline
Capex^
Adj capex*
21.4
14.0
16.6
7.1
7.8
4.7
3.9
4.6
FY25RE
FY26BE
10.7
13.4
10.8
FY25RE
^Excluding Loans & advances to states and capital infusion into PSUs
*Excluding ‘New Schemes’ under the Ministry of Finance
#CPSEs capex excluding DF&PD
Source: Budget documents, MOFSL
Nikhil Gupta
– Research analyst
(Nikhil.Gupta@MotilalOswal.com)
Tanisha Ladha
– Research analyst
(Tanisha.Ladha@MotilalOswal.com)
Investors are advised to refer through important disclosures made at the last page of the Research Report.
Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.
 Motilal Oswal Financial Services
FUEL
R ENGINES
What is the Center’s true capex budgeted for FY26BE?
Based on the headline data,
the growth in the Center’s capital spending is revised to 7.3% YoY in FY25RE (from
16.9% YoY in FY25BE) and is budgeted to grow 10.1% YoY in FY26BE. CPSEs’ capex is
budgeted to grow 12.9% YoY in FY26BE compared with a decline of 1.9% YoY in
FY25RE (13.0% YoY in FY25BE).
We must, however, make three adjustments to the headline data to understand the
extent of GoI’s true capex. Let’s discuss them one by one.
Exhibit 3: Detailed analysis of capital outlays by CG and CPSEs
INR b, unless otherwise mentioned
FY23
FY24
Central government capital spending (Budgeted allocation)
Ministry of Defense
1,429
1,543
Ministry of Railways
Ministry of Road Transport & Highways
Department of Telecommunications
Capital infusion to BSNL
Police
Others
2
FY25BE
1,720
2,520
2,722
844
831
101
1,472
1,715
1,424
11,111
(16.9 )
8,856
4
4
FY25RE
1,595
2,520
2,589
750
721
158
922
1,707
1,394
10,184
(7.3)
8,070
(4.9)
36
130
707
1,289
421
250
992
3,824
(-1.9)
3,574
(4.4)
1,631
2,650
2,589
11,644
(3.6)
4.7
FY26BE
1,800
2,520
2,591
502
339
118
1,381
2,258
3
1,593
2,105
556
82
482
1,153
927
7,400
(24.8)
6,207
1
2,426
2,699
605
568
98
511
1,611
1,229
9,492
(28.3)
7,695
266
Includes transfer of INR265b to
universal service obligation fund
2
1
Loans and advances (L&As)
States/UTs/foreign governments
Total capital spending (% YoY)
Capital outlays (Capex, % YoY)
5
Includes INR626b/INR91b/INR417b
in FY25BE/FY25RE/FY26BE as ‘New
Schemes’ under MoF
3
1,706
11,211
(10.1)
9,166
(13.6)
5
Includes INR200b for ‘other
scientific research’
4
FY25BE over FY24RE
(22.2)
(24.0)
(15.0 )
Central Public Sector Enterprises (CPSEs)
Ministry of Defense
Ministry of Railways
Ministry of Power
Ministry of Petroleum & Natural Gas
Ministry of Housing & Urban
development
Food corporation of India (FCI)
Others
Total capital outlays (% YoY)
Total capex (Excluding FCI, % YoY)
28
447
574
1,190
165
305
922
3,631
(-17.0)
3,326
32
196
544
1,369
234
477
1,048
3,900
(7.4)
3,423
33
130
667
1,185
425
270
977
3,686
(13.0 )
3,417
4
4
41
130
858
1,324
622
280
1,061
4,316
(12.9)
4,036
(12.9)
1,841
2,650
2,591
13,202
(3.7)
13.4
Excluding capital infusion into PSUs
and L&As to states
6
Excluding capital infusion into
PSUs, L&As to states and FCI’s capex
(but including ‘New Schemes’)
(-11.7)
(2.9)
(12.5 )
6
Combined capital outlays (Capex)
1,457
2,040
2,105
9,534
(3.5)
7.8
1,575
2,621
2,699
11,118
(3.8)
16.6
1,753
2,650
2,722
12,273
(3.7)
14.3
4
Ministry of Defense
Ministry of Railways
Ministry of Road Transport & Highways
Combined capex
(as a percentage of GDP)
YoY (%)
6
Source: Union Budget documents, MOFSL
4 February 2025
2
 Motilal Oswal Financial Services
FUEL
R ENGINES
Excluding L&As to states,
the GoI’s capex is budgeted
at INR9.5t in FY26BE, up
8.1% YoY, following an
average growth of 22%
during FY21-FY25RE
a. Segregate capital outlays (capex) from L&As:
Capital spending by the GoI has
two components – capex and L&As. From an average of ~10% in the pre-
pandemic years, L&As accounted for ~17% of GoI’s total capital spending in FY25
and they are budgeted to grow significantly to 20% in FY26, which is the highest
share since FY05, barring FY21.
The GoI has budgeted L&As worth INR2.3t in FY26BE (32.3% YoY growth in
FY26BE), including a transfer of INR1.7t to states. These L&As will be eventually
counted as states’ capex, and thus, they must be excluded from the GoI’s capex.
Excluding L&As to states, the GoI’s capex is budgeted at INR9.5t in FY26BE, up
8.1% YoY, following an average growth of 22% during FY21-FY25RE.
A total of INR1.89t has been
allocated during the past
four years as capital
infusion into BSNL under
the GoI’s capital spending
b. Equity infusion into PSUs must also be excluded:
A detailed ministry-wise
analysis of the capex also reveals that the Department of Telecommunications
(DoT) has included financial relief/capital infusion totaling INR266b into BSNL in
FY23 (down from INR447b/INR333b in FY23BE/FY23RE), INR568b in FY24 (down
from INR648b in FY24RE), INR721b in FY25RE (down from INR831b in FY25BE)
and another INR339b in FY26BE. Thus, a total of INR1.89t has been allocated
during the past four years as capital infusion into BSNL under the GoI’s capital
spending. These capital infusions pushed the allocation under the Ministry of
Communications from less than INR40b in FY22 to INR750b in FY25RE and
INR502b in FY26BE.
After excluding L&As to states and such financial support to various PSUs, the GoI’s
capex is budgeted at INR9.2t, up 13.6% YoY in FY26BE, following an average growth
of 20% during FY21-FY25RE
(Exhibit 3 on the preceding page).
The growth in capital
spending, excluding L&As to states and equity infusion into PSUs, is higher than the
growth in headline capital spending because of a lower number budgeted for equity
infusion into BSNL (INR339b in FY26BE vs. INR721b in FY25RE).
c. ‘New Schemes’ under the Ministry of Finance:
Further, the GoI has allocated a
sum of INR417b as ‘New Schemes’ under other expenditure in the Department
of Economic Affairs, Ministry of Finance (included under Others in
Exhibit 3
above). We could not find any details regarding this line item, just like in the
FY25 budget. We understand that this amount could be allocated against some
schemes that are work-in-progress but not sure about it. A similar allocation of
INR626b was made in FY25BE, which is now revised down to INR91b in FY25RE.
In fact, a large part of the downward revision in the Center’s capex in FY25 was
on account of this item, which makes us believe that the adverse economic
impact was limited.
After excluding L&As to
states and such financial
support to various PSUs, the
GoI’s capex is budgeted to
rise 13.6% YoY in FY26BE
If we further exclude
INR417b under ‘New
schemes’, the GoI’s
adjusted capex is budgeted
to grow 9.7% YoY this year
If we do not exclude ‘New Schemes’, the GoI’s capex is budgeted to grow 13.6% YoY
in FY26BE. However, if we further exclude INR417b, the GoI’s adjusted capex is
budgeted to grow 9.7% YoY this year
(see Exhibit 1).
Internal and Extra Budgetary Resources (IEBR) of CPSEs budgeted to grow at an
eight-year high pace in FY26:
Budget allocations only account for a portion of the
total capital spending by the GoI. The planned capital outlays (or capex) by CPSEs,
4 February 2025
3
 Motilal Oswal Financial Services
FUEL
R ENGINES
and their likely financing, are also provided for in the Union Budget. From an
economic perspective, what matters is the combined capital outlay of the GoI and
CPSEs.
Excluding FCI, IEBR of CPSEs
is budgeted to increase
12.9% YoY in FY26BE, the
highest in eight years
After making the above-mentioned adjustments in the GoI’s investment spending,
we have made one adjustment in CPSEs’ capex. Since FY18, the DF&PD (which
includes the allocation to FCI) has undertaken the maximum capital outlays among
CPSEs, averaging about INR2t each year during FY18-FY20. As the GoI cleared all the
arrears in FY21 and took over FCI debt on its books, the off-budget capex by the
DF&PD reduced to about INR600b in the following two years, i.e., FY21-FY22, before
falling further to INR200-300b in the last four years (FY23-FY26BE). This, we believe,
must be excluded from the aggregate IEBR of CPSEs to understand the true extent of
the infrastructure push by the GoI. Excluding FCI, IEBR of CPSEs is budgeted to
increase 12.9% YoY in FY26BE, the highest growth in the last eight years
(Exhibit 4).
Exhibit 5: Actual CPSEs’ capex met BEs in FY24, though
averaged 95% in the past decade
IEBR of CPSEs# (%)
Actual/BEs
Exhibit 4: CPSEs’ capex (excl. FCI) is budgeted to increase at
eight-year high pace of 12.9% YoY in FY26BE
CPSEs capex#
2.3
2.3
2.3
2.1
1.6
18.2
10.7
4.6
-9.0
FY18
FY20
-10.5
-11.7
FY22
FY24
FY26BE
2.9
4.4
1.2
1.2
1.1
1.1
12.9
% of GDP (rs)
% YoY
101
92
78
74
98
85
104
109
103
93
87
100
78
FY12
FY14
FY16
FY18
FY20
FY22
FY24
#Excluding FCI allocations
Source: Budget documents, CSO, MOFSL
Actual capex by CPSEs tends
to be 90-95% of BEs/REs,
with much sharper cuts vs.
BEs in FY22 and FY23
At the same time, historical data suggests actual capex by CPSEs tends to be about
90-95% of the budgeted and revised estimates (BEs/REs), with much sharper cuts vs.
BEs in FY22 and FY23
(Exhibit 5).
CPSEs’ capex was revised down to INR3t in FY24,
from INR3.4t in FY24BE. However, in FY25RE, CPSEs capex was higher than what was
budgeted (INR3.6t in FY25RE vs. INR3.4t in FY25BE). Therefore, it is not necessary
that CPSEs’ capex for FY26 would be revised lower.
Low base pushes combined capex growth to 13.4% YoY in FY26BE; budgeted at
3.7% of GDP, lower than in pre-Covid years:
Overall, from an economic perspective,
what matters is the combined capex of the GoI (on-budget) and IEBRs of CPSEs (off-
budget). With various adjustments (excluding L&As to states, capital infusion to
PSUs and DF&PD from CPSEs), our estimates suggest that the combined capital
outlays grew 4.7% YoY in FY25RE and were budgeted to rise by 13.4% YoY in FY26
(see Exhibit 2 above).
The combined capex, thus, is budgeted at 3.7% of GDP in FY26BE, better than 3.6%
in FY25RE but lower than 3.8% of GDP in FY24 and 3.9% of GDP in the pre-Covid
years
(Exhibit 6).
The combined capex (of the
Center and CPSEs) is
budgeted at 3.7% of GDP in
FY26, higher than 3.6% in
FY25RE, but lower than the
pre-Covid period
4 February 2025
4
 Motilal Oswal Financial Services
FUEL
Exhibit 6: Combined capital outlays of the government and CPSEs
Capital outlays (% of GDP)
4.0
3.5
2.3
2.3
3.9
3.3
2.3
1.8
2.2
2.3
2.3
2.3
4.0
3.9
3.8
3.9
Centre#
3.9
CPSEs*
3.6
Combined/Aggregate
3.7
1.6
3.5
1.2
3.8
1.2
R ENGINES
3.6
1.1
3.7
1.1
1.9
2.1
1.7
FY12
1.5
FY13
1.6
FY14
1.5
FY15
1.7
FY16
1.7
FY17
1.5
FY18
1.6
FY19
1.6
FY20
1.5
FY21
2.2
2.3
2.6
2.5
2.6
FY22
FY23
FY24
FY25RE FY26BE
#Excluding L&As to states and equity infusion to PSUs
*Excluding FCI
Source: Union Budget documents, CSO, MOFSL
After adjusting the Center’s
capex by INR417b allocated
as ‘New Schemes’, the
combined capex will fall to
3.6% of GDP this year
After adjusting the Center’s capex by INR417b allocated as ‘New Schemes’ under the
Ministry of Finance, the Center’s capex growth will be 9.7% and the combined capex
growth will be 10.7% YoY in FY26BE
(see Exhibit 2 above).
Accordingly, the combined
capex will fall to 3.6% of GDP next year.
‘Grants-in-aid for creation of capital assets’ must not be included in the Center’s
capex:
Unlike in the past years, there is an argument that the grants-in-aid to states
for the creation of capital assets should also be included in the Center’s capex. Such
grants are budgeted at INR4.3t in FY26BE, with a 14-year high growth of 42.4% YoY,
compared with a fall of 1.3% YoY in FY25RE (21.7% YoY in FY25BE). If we add these
grants to the combined capex discussed above, the aggregate capex is budgeted at
INR19.8t in FY26BE from INR17.0t in FY25RE (INR 18.7tn in FY25BE), implying a
growth of 16.4% YoY next year, compared with revised growth of 3.5% this year
(from 17.1% YoY in FY25BE).
There are good reasons why ‘grants for creation of capital assets’ should not be
included in the Center’s capex. Many of these schemes, such as MGNREGA or PM
Surya Ghar Muft Bijli Yojana, are not capex
(Exhibit 7).
Exhibit 7: Key allocations under ‘Grants for creation of capital assets’
(INR b)
MGNREGA
Jal Jeevan mission/National Rural drinking water mission
Pradhan Mantri Awaas Yojana – Gramin (PMAY-G)
PM Surya Ghar Muft Bijli Yojana – New & renewable
energy
Pradhan Mantri Gram Sadak Yojna (PMGSY)
Pradhan Mantri Awaas Yojana – Urban (PMAY-U)
Reform Linked Distribution Scheme – Power
Transfer to states
Urban challenge fund
Road works
Others
Total (% YoY)
Arranged as per top 10 schemes in FY26BE
FY23
902
507
411
189
154
25
70
75
730
3,063 (26.2)
FY24
888
647
192
140
197
98
65
86
726
3,039 (-0.8)
FY25BE
853
651
506
56
FY25RE
853
210
286
102
FY26BE
854
625
509
190
189
144
189
236
115
172
123
124
158
193
190
150
100
87
87
95
1,031
888
1,229
3,908 (21.7)
2,999 (-1.3)
4,272 (42.4)
Source: Union Budget documents, CSO, MOFSL
4 February 2025
5
 Motilal Oswal Financial Services
FUEL
R ENGINES
Just like the Center’s loans, if these grants are spent on capex by states, then they
would form a part of states’ capex. Therefore, we must exclude them from the
Center’s budgeted capex to avoid double counting.
Just like the Center’s loans,
if these grants are spent on
capex by states, then they
would form a part of states’
capex
Interestingly, it is not clear if the states classify all these expenditures as capex. For
instance, the Center’s grants to states for capital assets’ creation under the
Department of Rural Development (excluding MGNREGA and considering only
PMAY-G and PMGSY) totaled INR420b/INR600n in FY22/FY23. In contrast, states’
aggregate capex under this Department was lower at about INR300b and INR400b,
respectively.
If one argues that a lot of spending under such grants actually represents capex, and
thus, should ideally be included under capex, then one must also note that a part of
spending under capex budget is actually current expenditure (wages/salaries etc.),
and thus, should be excluded. Since such reclassification is impossible for any
outsider (and not sure if even the government can conduct such an exercise), it is
better to estimate capex budget under the existing classifications.
Therefore, we keep grants for the creation of capital assets outside the capex
estimates.
Accordingly, the combined capex of the Center and CPSEs (excluding loans &
advances to states, capital infusion into PSUs and FCI’s capex) is budgeted to grow
13.4% of GDP in FY26, supported by a low base of 4.7% in FY25RE (revised down
from 14.3% in FY25BE). It is budgeted at 3.7% of GDP in FY26, slightly better than
3.6% of GDP in FY25RE, but lower than in the pre-Covid years (or 3.8% in FY24).
Overall, for the first time in almost a decade, the GoI focused more on consumption
and savings rather than capex. We need to keep a keen eye on whether this change
is a one-off or if it suggests a change in the paradigm.
Investment in securities market are subject to market risks. Read all the related documents carefully before investing
4 February 2025
6
 Motilal Oswal Financial Services
FUEL
Explanation of Investment Rating
Investment Rating
BUY
SELL
NEUTRAL
UNDER REVIEW
NOT RATED
Expected return (over 12-month)
>=15%
< - 10%
> - 10 % to 15%
Rating may undergo a change
We have forward looking estimates for the stock but we refrain from assigning recommendation
R ENGINES
*In case the recommendation given by the Research Analyst is inconsistent with the investment rating legend for a continuous period of 30 days, the Research Analyst shall within following 30 days take
appropriate measures to make the recommendation consistent with the investment rating legend.
Disclosures:
The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).
Motilal Oswal Financial Services Ltd. (MOFSL) is a SEBI Registered Research Analyst having registration no. INH000000412. MOFSL, the Research Entity (RE) as defined in the Regulations, is engaged in
the business of providing Stock broking services, Depository participant services & distribution of various financial products. MOFSL is a listed public company, the details in respect of which are available on
www.motilaloswal.com.
MOFSL (erstwhile Motilal Oswal Securities Limited - MOSL) is registered with the Securities & Exchange Board of India (SEBI) and is a registered Trading Member with National Stock
Exchange of India Ltd. (NSE) and Bombay Stock Exchange Limited (BSE), Multi Commodity Exchange of India Limited (MCX) and National Commodity & Derivatives Exchange Limited (NCDEX) for its stock
broking activities & is Depository participant with Central Depository Services Limited (CDSL) National Securities Depository Limited (NSDL),NERL, COMRIS and CCRL and is member of Association of
Mutual Funds of India (AMFI) for distribution of financial products and Insurance Regulatory & Development Authority of India (IRDA) as Corporate Agent for insurance products. Details of associate entities of
Motilal Oswal Financial Services Ltd. are available on the website at
http://onlinereports.motilaloswal.com/Dormant/documents/Associate%20Details.pdf
Details of pending Enquiry Proceedings of Motilal Oswal Financial Services Limited are available on the website at
https://galaxy.motilaloswal.com/ResearchAnalyst/PublishViewLitigation.aspx
MOFSL, it’s associates, Research Analyst or their relatives may have any financial interest in the subject company. MOFSL and/or its associates and/or Research Analyst or their relatives may have actual
beneficial ownership of 1% or more securities in the subject company at the end of the month immediately preceding the date of publication of the Research Report or date of the public appearance.
MOFSL
and its associate company(ies), their directors and Research Analyst and their relatives may have any other potential conflict of interests at the time of publication of the research report or at the time of public
appearance, however the same shall have no bearing whatsoever on the specific recommendations made by the analyst(s), as the recommendations made by the analyst(s) are completely independent of the
views of the associates of MOFSL even though there might exist an inherent conflict of interest in some of the stocks mentioned in the research report.
In the past 12 months, MOFSL or any of its associates may have:
a)
received any compensation/other benefits from the subject company of this report
b)
managed or co-managed public offering of securities from subject company of this research report,
c)
received compensation for investment banking or merchant banking or brokerage services from subject company of this research report,
d)
received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company of this research report.
MOFSL and it’s associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
Subject Company may have been a client of MOFSL or its associates during twelve months preceding the date of distribution of the research report.
Research Analyst may have served as director/officer/employee in the subject company.
MOFSL and research analyst may engage in market making activity for the subject company.
MOFSL and its associate company(ies), and Research Analyst and their relatives from time to time may have:
a) a long or short position in, act as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein.
(b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act
as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.; however the same
shall have no bearing whatsoever on the specific recommendations made by the analyst(s), as the recommendations made by the analyst(s) are completely independent of the views of the associates of
MOFSL even though there might exist an inherent conflict of interest in some of the stocks mentioned in the research report.
Above disclosures include beneficial holdings lying in demat account of MOFSL which are opened for proprietary investments only. While calculating beneficial holdings, It does not consider demat accounts
which are opened in name of MOFSL for other purposes (i.e holding client securities, collaterals, error trades etc.). MOFSL also earns DP income from clients which are not considered in above disclosures.
To enhance transparency, MOFSL has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. MOFSL
and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this report should be aware that MOFSL may have a
potential conflict of interest that may affect the objectivity of this report.
Terms & Conditions:
This report has been prepared by MOFSL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any
way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of MOFSL. The report is based on the facts, figures
and information that are considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources
believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such
information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or
subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. MOFSL will not treat
recipients as customers by virtue of their receiving this report.
Analyst Certification
The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or
will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report.
Disclosure of Interest Statement
Companies where there is interest
Analyst ownership of the stock
No
A graph of daily closing prices of securities is available at
www.nseindia.com, www.bseindia.com.
Research Analyst views on Subject Company may vary based on Fundamental research and Technical
Research. Proprietary trading desk of MOFSL or its associates maintains arm’s length distance with Research Team as all the activities are segregated from MOFSL research activity and therefore it can have
an independent view with regards to subject company for which Research Team have expressed their views.
Regional Disclosures (outside India)
This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to
law, regulation or which would subject MOFSL & its group companies to registration or licensing requirements within such jurisdictions.
For Hong Kong:
This report is distributed in Hong Kong by Motilal Oswal capital Markets (Hong Kong) Private Limited, a licensed corporation (CE AYY-301) licensed and regulated by the Hong Kong Securities and Futures
Commission (SFC) pursuant to the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) “SFO”. As per SEBI (Research Analyst Regulations) 2014 Motilal Oswal Financial Services
Limited (SEBI Reg No. INH000000412) has an agreement with Motilal Oswal capital Markets (Hong Kong) Private Limited for distribution of research report in Hong Kong. This report is intended for
distribution only to “Professional Investors” as defined in Part I of Schedule 1 to SFO. Any investment or investment activity to which this document relates is only available to professional investor and will be
engaged only with professional investors.” Nothing here is an offer or solicitation of these securities, products and services in any jurisdiction where their offer or sale is not qualified or exempt from
registration. The Indian Analyst(s) who compile this report is/are not located in Hong Kong & are not conducting Research Analysis in Hong Kong.
For U.S.
MOTILAL Oswal Financial Services Limited (MOFSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the
United States. In addition MOFSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under
applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOFSL, including the products and services
described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and
4 February 2025
7
 Motilal Oswal Financial Services
FUEL
R ENGINES
interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment
or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration
provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to
conduct business with Institutional Investors based in the U.S., MOFSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited.
("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this chaperoning agreement.
The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer,
MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research
analyst account.
For Singapore
In Singapore, this report is being distributed by Motilal Oswal Capital Markets (Singapore) Pte. Ltd. (“MOCMSPL”) (UEN 201129401Z), which is a holder of a capital markets services license and an exempt
financial adviser in Singapore.This report is distributed solely to persons who (a) qualify as “institutional investors” as defined in section 4A(1)(c) of the Securities and Futures Act of Singapore (“SFA”) or (b)
are considered "accredited investors" as defined in section 2(1) of the Financial Advisers Regulations of Singapore read with section 4A(1)(a) of the SFA. Accordingly, if a recipient is neither an “institutional
investor” nor an “accredited investor”, they must immediately discontinue any use of this Report and inform MOCMSPL .
In respect of any matter arising from or in connection with the research you could contact the following representatives of MOCMSPL. In case of grievances for any of the services rendered by MOCMSPL
write to
grievances@motilaloswal.com.
Nainesh Rajani
Email:
nainesh.rajani@motilaloswal.com
Contact: (+65) 8328 0276
Disclaimer:
The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any
other person or to the media or reproduced in any form, without prior written consent. This report and information herein is solely for informational purpose and may not be used or considered as an offer
document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that
any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their
own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any
recipient. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this
document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be
suitable for all investors. Certain transactions -including those involving futures, options, another derivative products as well as non-investment grade securities - involve substantial risk and are not suitable for
all investors. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions contained in this document. The Disclosures of Interest
Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. This information is subject to change
without any prior notice. The Company reserves the right to make modifications and alternations to this statement as may be required from time to time without any prior approval. MOFSL, its associates, their
directors and the employees may from time to time, effect or have effected an own account transaction in, or deal as principal or agent in or for the securities mentioned in this document. They may perform or
seek to perform investment banking or other services for, or solicit investment banking or other business from, any company referred to in this report. Each of these entities functions as a separate, distinct
and independent of each other. The recipient should take this into account before interpreting the document. This report has been prepared on the basis of information that is already available in publicly
accessible media or developed through analysis of MOFSL. The views expressed are those of the analyst, and the Company may or may not subscribe to all the views expressed therein. This document is
being supplied to you solely for your information and may not be reproduced, redistributed or passed on, directly or indirectly, to any other person or published, copied, in whole or in part, for any purpose. This
report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution,
publication, availability or use would be contrary to law, regulation or which would subject MOFSL to any registration or licensing requirement within such jurisdiction. The securities described herein may or
may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
Neither the Firm, not its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that
may arise from or in connection with the use of the information.
The person accessing this information specifically agrees to exempt MOFSL or any of its affiliates or employees from, any and all
responsibility/liability arising from such misuse and agrees not to hold MOFSL or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOFSL or any of its affiliates or
employees free and harmless from all losses, costs, damages,
expenses that may be suffered by the person accessing this information due to any errors and delays.
This report is meant for the clients of Motilal Oswal only.
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Registered Office Address: Motilal Oswal Tower, Rahimtullah Sayani Road, Opposite Parel ST Depot, Prabhadevi, Mumbai-400025; Tel No.: 022 - 71934200 / 71934263; www.motilaloswal.com.
Correspondence Address: Palm Spring Centre, 2nd Floor, Palm Court Complex, New Link Road, Malad (West), Mumbai- 400 064. Tel No: 022 71881000. Details of Compliance Officer: Neeraj Agarwal, Email
Id: na@motilaloswal.com, Contact No.:022-40548085.
Grievance Redressal Cell:
Contact Person
Ms. Hemangi Date
Ms. Kumud Upadhyay
Mr. Ajay Menon
Contact No.
022 40548000 / 022 67490600
022 40548082
022 40548083
Email ID
query@motilaloswal.com
servicehead@motilaloswal.com
am@motilaloswal.com
Registration details of group entities.: Motilal Oswal Financial Services Ltd. (MOFSL): INZ000158836 (BSE/NSE/MCX/NCDEX); CDSL and NSDL: IN-DP-16-2015; Research Analyst: INH000000412 . AMFI:
ARN .: 146822. IRDA Corporate Agent – CA0579. Motilal Oswal Financial Services Ltd. is a distributor of Mutual Funds, PMS, Fixed Deposit, Insurance, Bond, NCDs and IPO products.
Customer having any query/feedback/ clarification may write to query@motilaloswal.com. In case of grievances for any of the services rendered by Motilal Oswal Financial Services Limited (MOFSL) write to
grievances@motilaloswal.com, for DP to dpgrievances@motilaloswal.com.
4 February 2025
8